SMARCA4-associated schwannomatosis

Affiliations

• ¹ Department of Human Genetics, McGill University, Montreal, QC, Canada.
• ² Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.
• ³ Molecular Mechanisms and Experimental Therapy in Oncology Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
• ⁴ Institute of Human Genetics, Ulm University and Ulm University Medical Centre, Ulm, Germany.
• ⁵ Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
• ⁶ Department of Human Genetics, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
• ⁷ Anatomical Pathology, Canterbury Health Laboratories, Christchurch, New Zealand.
• ⁸ Pathology Queensland, Faculty of Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
• ⁹ Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.
• ¹⁰ Department of Human Genetics, McGill University, Montreal, QC, Canada. william.foulkes@mcgill.ca.
• ¹¹ Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada. william.foulkes@mcgill.ca.
• ¹² Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada. william.foulkes@mcgill.ca.
• ¹³ Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada. william.foulkes@mcgill.ca.